129;B6-Tg(Atm-ERT2-LBD)G3Mpel/Cnrm

Status

Under development - register interest

EMMA IDEM:16174
Citation informationRRID:IMSR_EM:16174 

Research Resource Identifiers (RRID) are persistent unique ID numbers assigned to help researchers cite key resources (e.g. antibodies, model organisms and software projects) in the biomedical literature to improve transparency and reproducibility in research. See https://www.rrids.org/ for more information.

 
International strain name129;B6-Tg(Atm-ERT2-LBD)G3Mpel/Cnrm
Alternative nameAtm TgERT2-LBD Atm+/+
Strain typeTransgenic Strains
Allele/Transgene symbolAtm TgERT2-LBD
Gene/Transgene symbolAtm TgERT2-LBD

Information from provider

ProviderManuela Pellegrini
Provider affiliationIBBC-CNR
Genetic informationThe ERT2-LBD fragment, from the pCre-ERT2 plasmid, was inserted into Atm BAC RP24 122F1026 by homologous recombination to obtain Atm-ERT2-LBD transgenic mice.
Phenotypic informationHomozygous:
Atm wild-type and heterozygous knock-out mice are normal. Atm homozygous knock-out mice show immunodeficiency, weight loss, radio-sensibility, lymphoma predisposition, male and female sterility. In absence of tamoxifen administration, no specific phenotype of the Atm TgERT2-LBD transgene in Atm wild-type or knock-out background is observed. However as we reported in Di Siena et al. (2018; PubMed ID:29472706; doi:10.1038/s41419-018-0357-8), upon tamoxifen administration body weight, immunodeficiency, spermatogenesis and radio-resistance are recovered in transgenic mice on Atm knock-out background. After tamoxifen-induced restoration of Atm expression life span is doubled, mice are protected from thymoma and no cerebellar defects are observed. Atm signaling is also functional after DNA damage.

Heterozygous:
Atm wild-type and heterozygous knock-out mice are normal. Atm homozygous knock-out mice show immunodeficiency, weight loss, radio-sensibility, lymphoma predisposition, male and female sterility. In absence of tamoxifen administration, no specific phenotype of the Atm TgERT2-LBD transgene in Atm wild-type or knock-out background is observed. However as we reported in Di Siena et al. (2018; PubMed ID:29472706; doi:10.1038/s41419-018-0357-8), upon tamoxifen administration body weight, immunodeficiency, spermatogenesis and radio-resistance are recovered in transgenic mice on Atm knock-out background. After tamoxifen-induced restoration of Atm expression life span is doubled, mice are protected from thymoma and no cerebellar defects are observed. Atm signaling is also functional after DNA damage.
Breeding historyThe final targeting vector was purified for pronuclear injection into C57BL/6 oocytes. Several transgenic founder lines were obtained and crossed to Atm+/- knock-out mice on 129/SvEv background in order to test restoration of Atm transgenic expression in the Atm wild-type, heterozygous or homozygous null background. The submitted Tg(Atm-ERT2-LBD) G3 line does not carry the Atm knock-out allele.
References
  • Atm reactivation reverses ataxia telangiectasia phenotypes in vivo.;Di Siena Sara, Campolo Federica, Gimmelli Roberto, Di Pietro Chiara, Marazziti Daniela, Dolci Susanna, Lenzi Andrea, Nussenzweig Andre, Pellegrini Manuela, ;2018;Cell death & disease;9;314; 29472706
Homozygous fertileyes
Homozygous viableyes
Homozygous matings requiredno
Immunocompromisedyes

Information from EMMA

Archiving centreCNR, Consiglio Nazionale delle Ricerche, Monterotondo, Italy

Literature references

  • Atm reactivation reverses ataxia telangiectasia phenotypes in vivo.;Di Siena Sara, Campolo Federica, Gimmelli Roberto, Di Pietro Chiara, Marazziti Daniela, Dolci Susanna, Lenzi Andrea, Nussenzweig Andre, Pellegrini Manuela, ;2018;Cell death & disease;9;314; 29472706

Information on how we integrate external resources can be found here

Register interest

Availabilities

Requesting frozen sperm or embryos is generally advisable wherever possible, in order to minimise the shipment of live mice.

  • Frozen embryos. Delivered in 4 weeks (after paperwork in place). €1740*
  • Frozen sperm. Delivered in 4 weeks (after paperwork in place). €1740*
  • Rederivation of mice from frozen stock, delivery time available upon request . €3880*

Due to the dynamic nature of our processes strain availability may change at short notice. The local repository manager will advise you in these circumstances.

* In addition users have to cover all the shipping costs (including the cost for returning dry-shippers, where applicable).

More details on pricing and delivery times

Practical information

Example health report
(Current health report will be provided later)

Material Transfer Agreement (MTA)
For this strain no provider MTA is needed. Distribution is based on the EMMA conditions only.

EMMA conditions
Legally binding conditions for the transfer

Right strain for your research?

The information provided on this page is, to the best of EMMA’s knowledge, based on data supplied by the original provider. End users are responsible for reviewing these details and for validating the strain and its suitability for their experimental use.​
Not found what you were looking for? Search here for other strains available from EMMA.


Search
INFRAFRONTIER® and European Mouse Mutant Archive - EMMA® are registered trademarks at the European Union Intellectual Property Office (EUIPO).